NiravolineAlternative Names: Niravolin; RU 49679
Latest Information Update: 08 Jul 2002
At a glance
- Originator Aventis
- Class Benzeneacetamides; Heart failure therapies; Pyrrolidines; Small molecules
- Mechanism of Action Diuretics; Opioid kappa receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Brain oedema; Heart failure; Liver cirrhosis